Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Rolika Bansal MBBS, MS (Ophth)

Rolika Bansal MBBS, MS (Ophth)

International Fellow, Ocular Oncology, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania
  • MBBS: Kasturba Medical College, Manipal, Karnataka
  • MS: Ophthalmology: KLESH, Belagavi, Karnataka (First position)
  • Fellowship: Ocular Oncology and Oculoplasty under the mentorship of Dr. Santosh Honavar, Centre for Sight, Hyderabad
  • Current position: International fellow in Ocular Oncology at Wills Eye Hospital, Philadelphia, USA under the mentorship of Dr. Carol L Shields
  • Won 44 awards in Ophthalmology including the IOFF-Retina Research Foundation Helmerich Subspeciality Fellowship Award 2023, International Heroes Award AIOC 2023, Col Rangachari Award for the best paper at AIOC 2022, Sujata Savitri Rao award for the best paper in orbit and oculoplasty at AIOC 2022, Best paper, poster podium, and physical poster at AIOS 2022, AIOS 2023, Ramana Rao Grand Rounds award at TOS 2022, IJO Platinum award for publication on ROCM at AIOC 2022, Best of IJO innovation award at AIOC 2022 (for the PG thesis), Best paper in orbit and ocular oncology at SAOCON 2022, Gold medal for Best poster at ROSCON 2021, Manoj Mathur award for the best poster at TOS 2021
  • Travel grant winner for ISOO 2022, WOC 2022 and APAO 2023; STS ICMR grant in 2012
  • 48 research projects, including 2 clinical trials, 43 publications (28 indexed) and 3 book chapters.
  • Attended and presented research work at various national and international conferences

Recent Contributions to PracticeUpdate:

  1. Primary Cemiplimab Treatment for Orbital Squamous Cell Carcinoma Is Effective and May Alleviate the Need for Orbital Exenteration

Most Read This Week

Recently Updated